CJC-1295 & GHRP-2 Blend (10mg) – Premium Dual-Action GH Research Peptide

Welcome to Liaocheng Yixin Company, your trusted source for premium cjc-1295 ghrp-2 10mg blend for research. As a specialized peptide synthesis manufacturer operating from our facility at No. 9 Lushan Road, Dongcheng Street, Liaocheng Economic and Technological Development Zone, Shandong Province, we provide high-quality research compounds for the global scientific community.  cjc-1295 ghrp-2 10mg blend for research

This 10mg dual blend combines CJC-1295 (without DAC, also known as Modified GRF 1-29) with GHRP-2, creating one of the most researched and popular synergistic stacks for growth hormone axis investigation. CJC-1295 acts as a GHRH analog that engages the GHRH receptor on pituitary somatotrophs, while GHRP-2 activates the ghrelin receptor (GHS-R1a). When paired, these peptides target complementary receptor systems, resulting in a synergistic amplification of GH output that exceeds the additive sum of either peptide alone. Our cjc-1295 ghrp-2 10mg blend for research offers investigators a convenient, precisely formulated tool for endocrine signaling, metabolic research, and tissue regeneration studies. cjc-1295 ghrp-2 10mg blend for research

What is the CJC-1295 & GHRP-2 Blend?

This 10mg lyophilized blend contains two research peptides that work through complementary mechanisms at the hypothalamic-pituitary axis:

CJC-1295 without DAC is a tetrasubstituted GHRH analog with amino acid substitutions at positions 2, 8, 15, and 27 that protect it from rapid enzymatic degradation. GHRP-2 is a synthetic hexapeptide that acts as a potent agonist of the growth hormone secretagogue receptor type 1a (GHS-R1a), the endogenous receptor for ghrelin.

Mechanism of Action in Research

The blend combines two distinct pathways to produce synergistic GH release:

GHRH Receptor Pathway (CJC-1295)

CJC-1295 binds the GHRH receptor (GHRHR) on anterior pituitary somatotrophs, activating Gs-coupled adenylyl cyclase signaling. This elevates intracellular cAMP, activates protein kinase A (PKA), and phosphorylates CREB to drive GH gene transcription (GH1) and prime somatotroph secretory vesicles for exocytosis. Without the Drug Affinity Complex (DAC), the peptide has a plasma half-life of approximately 30 minutes to 2 hours, producing a discrete, time-limited GH pulse that closely mimics the endogenous pulsatile pattern of GH secretion. CJC-1295 maintains physiologic pulsatile GH secretion patterns even under stimulation.

GHS-R1a Pathway (GHRP-2)

GHRP-2 activates the growth hormone secretagogue receptor type 1a (GHS-R1a), the endogenous ghrelin receptor, on pituitary somatotrophs. This triggers Gq-coupled phospholipase C (PLC) signaling, generating IP3 and DAG, mobilizing intracellular calcium from the endoplasmic reticulum, and activating protein kinase C (PKC). The resulting calcium influx directly triggers GH vesicle exocytosis.

Hypothalamic Effects of GHRP-2

GHRP-2 provides additional hypothalamic-level effects: it stimulates endogenous GHRH release from arcuate nucleus neurons and functionally suppresses somatostatin release from periventricular neurons. This dual hypothalamic action creates a permissive environment for maximal GH pulse amplitude. GHRP-2 also mildly stimulates ACTH, cortisol, and prolactin release—effects that researchers should consider in study design.  cjc-1295 ghrp-2 10mg blend for research

Synergistic Amplification

The combination of GHRH-pathway (cAMP/PKA) and ghrelin-pathway (PLC/PKC/Ca2+) activation produces synergistic GH release that substantially exceeds the sum of individual peptide effects. The synergy is scientifically well-documented: GHRP-2 increases the amplitude (size) of GH pulses, while GHRH analogs like CJC-1295 increase the frequency (how often) GH pulses occur. Together, they produce higher total daily GH output—more pulses and larger pulses. Research in healthy individuals demonstrated that combining GHRP-2 with GHRH produced synergistic effects, demonstrating the multiplicative nature of the combination.

Scientific Research Applications

Growth Hormone Secretagogue Research

The CJC-1295 and GHRP-2 blend is the most researched and popular synergistic stack for growth hormone axis investigation. It is studied for its ability to produce GH output that substantially exceeds predictions from simple additivity, establishing the pharmacological basis for GHRH/GHS blend formulations. The blend preserves natural GH rhythm while delivering synergistic IGF-1 elevation exceeding the sum of parts.  cjc-1295 ghrp-2 10mg blend for research

Metabolic and Body Composition Research

Growth hormone regulates metabolism, influencing processes such as lipolysis, glucose utilization, and insulin sensitivity. Investigations suggest this blend may influence energy metabolism through GH-mediated lipolysis and lipid oxidation pathways, potentially shifting metabolic balance toward fat utilization and improved glucose homeostasis. The blend may provide a compelling framework for studying metabolic diseases such as obesity and insulin resistance under controlled research protocols.

Tissue and Regenerative Research

GH and IGF-1 are central to anabolic signaling cascades, involving pathways implicated in protein synthesis and cellular growth. The blend is postulated to amplify downstream IGF-1 production through combined receptor engagement, potentially supporting inquiries into muscle cell regeneration, lean mass accrual, and connective tissue remodeling. Preliminary observations suggest increases in muscle tissue hypertrophy metrics and potential suppression of muscle-degrading enzymes.

Cardiac and Immune Research

The GHS-R1a receptor has been identified in cardiac tissue, where GHRP-2 and related peptides exert direct cardioprotective effects independent of GH release. Both GH-releasing pathways have been linked to immune reconstitution, with growth hormone and ghrelin signaling promoting thymic regeneration in aged animal models, restoring T-cell output and improving immune surveillance. cjc-1295 ghrp-2 10mg blend for research

Why Choose Liaocheng Yixin Company?

When sourcing cjc-1295 ghrp-2 10mg blend for research, quality and reliability are paramount. Here’s why researchers trust us:

Manufacturer-Direct Quality

We are a legitimate, licensed peptide synthesis company with a physical headquarters in Shandong Province, China. Our facility maintains strict quality control standards.

Verified Purity Standards

Every batch undergoes rigorous testing using HPLC analysis. Our blend meets ≥99% purity standards. Certificates of Analysis are available upon request.

Research-Grade Specifications

• Purity: ≥99% verified by HPLC

• Appearance: White lyophilized powder

• Storage: Store powder at -20°C in a sealed, desiccated container, protected from light and moisture

• Form: Lyophilized powder for research use

Quality Assurance & Testing

Every batch undergoes comprehensive quality control:

1. Synthesis by experienced chemists using solid-phase peptide synthesis

2. Purification via preparative HPLC

3. Analysis using HPLC for purity verification

4. Mass Spectrometry for molecular weight confirmation

5. Packaged in sterile conditions for research use

: How does the CJC-1295 and GHRP-2 blend work in research?

A: CJC-1295 activates the GHRH receptor on pituitary somatotrophs through the cAMP/PKA pathway, while GHRP-2 engages the ghrelin receptor (GHS-R1a) through Gq/11-coupled calcium mobilization. This dual-receptor activation produces synergistic GH output that exceeds the additive sum of either peptide alone. GHRP-2 also suppresses somatostatin tone at the hypothalamic level, removing a key brake on GH secretion.

: What distinguishes CJC-1295 No DAC from the DAC version?

A: CJC-1295 without DAC has a half-life of approximately 30 minutes to 2 hours, producing discrete, time-limited GH pulses that closely mimic endogenous pulsatile secretion. The DAC version extends half-life dramatically to approximately 8 days, creating sustained GH elevation rather than pulsatile release. The No DAC version is typically preferred for research that requires preserving natural GH rhythm.  cjc-1295 ghrp-2 10mg blend for research

: What are the key research applications for this blend?

A: This blend is used in growth hormone secretagogue research (synergy studies), metabolic and body composition research (lipolysis, glucose homeostasis), tissue and regenerative research, cardiac function studies, and immune system/thymus regeneration investigations.

: How does GHRP-2 differ from more selective GHRPs like Ipamorelin?

A: GHRP-2 is approximately 25% more potent for raw GH release but is less selective—it stimulates ACTH, cortisol, and prolactin alongside GH, and activates hypothalamic NPY/AgRP neurons involved in appetite regulation. This broader activation profile may contribute to metabolic effects beyond isolated GH release and is an important consideration for research design. cjc-1295 ghrp-2 10mg blend for research

: What purity level can I expect?

A: All batches are tested to ensure ≥99% purity by HPLC analysis. Certificates of Analysis are available upon request.

: Is this product for human use?

A: No. This blend is manufactured strictly for research use only (RUO). It is not intended for human consumption or clinical applications.

When you need premium cjc-1295 ghrp-2 10mg blend for research for your endocrine, metabolic, or regenerative studies, choose a manufacturer that prioritizes quality, transparency, and reliability. Liaocheng Yixin Company combines expert peptide synthesis capabilities with rigorous quality control to deliver research materials you can trust.